3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Experimental Mammary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coley, HM; Twentyman, PR; Workman, P | 1 |
Marquardt, H; Mohr, U; Westendorf, J | 1 |
2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Experimental Mammary Neoplasms
Article | Year |
---|---|
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |
Induction of malignant transformation in vitro and mammary tumors in rats by two new potent anthracycline antitumor antibiotics, morpholinodaunomycin and cyanomorpholinoadriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Carcinogenicity Tests; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Female; In Vitro Techniques; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains | 1987 |